These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6757015)

  • 1. The relative importance of first- and second-phase insulin secretion in countering the action of glucagon on glucose turnover in the conscious dog.
    Steiner KE; Mouton SM; Bowles CR; Williams PE; Cherrington AD
    Diabetes; 1982 Nov; 31(11):964-72. PubMed ID: 6757015
    [No Abstract]   [Full Text] [Related]  

  • 2. The interaction of insulin and glucagon on the liver.
    Rastogi GK
    J Assoc Physicians India; 1972 Nov; 20(11):859-66. PubMed ID: 4654918
    [No Abstract]   [Full Text] [Related]  

  • 3. Relative importance of first- and second-phase insulin secretion in glucose homeostasis in conscious dog. II. Effects on gluconeogenesis.
    Steiner KE; Mouton SM; Williams PE; Lacy WW; Cherrington AD
    Diabetes; 1986 Jul; 35(7):776-84. PubMed ID: 3522319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a role of endogenous insulin and glucagon in the regulation of potassium homeostasis.
    Santeusanio F; Faloona GR; Knochel JP; Unger RH
    J Lab Clin Med; 1973 Jun; 81(6):809-17. PubMed ID: 4710366
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of insulin and glucagon in obesity.
    Schade DS; Eaton RP
    Diabetes; 1974 Aug; 23(8):657-61. PubMed ID: 4854163
    [No Abstract]   [Full Text] [Related]  

  • 6. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
    Ross G; Lickley L; Vranic M
    Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of endogenous intestinal glucagon-like immunoreactivity (GLI) on insulin secretion and glucose concentration in dogs.
    Marco J; Faloona GR; Unger RH
    J Clin Endocrinol Metab; 1971 Aug; 33(2):318-25. PubMed ID: 5565608
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for an intrahepatic contribution to the waning effect of glucagon on glucose production in the conscious dog.
    Cherrington AD; Diamond MP; Green DR; Williams PE
    Diabetes; 1982 Oct; 31(10):917-22. PubMed ID: 6759225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon.
    Shulman GI; Liljenquist JE; Williams PE; Lacy WW; Cherrington AD
    J Clin Invest; 1978 Aug; 62(2):487-91. PubMed ID: 670404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of glucagon in countering hypoglycemia induced by insulin infusion in dogs.
    Dobbins RL; Connolly CC; Neal DW; Palladino LJ; Parlow AF; Cherrington AD
    Am J Physiol; 1991 Dec; 261(6 Pt 1):E773-81. PubMed ID: 1767838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and glucagon choleresis during normoglycemia.
    Meyers WC; Hanks JB; Jones RS
    Surg Forum; 1979; 30():398-400. PubMed ID: 395695
    [No Abstract]   [Full Text] [Related]  

  • 12. The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs.
    Vranic M; Kawamori R; Pek S; Kovacevic N; Wrenshall GA
    J Clin Invest; 1976 Feb; 57(2):245-55. PubMed ID: 1254723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.
    Sherwin RS; Hendler R; DeFronzo R; Wahren J; Felic P
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):348-52. PubMed ID: 264686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon physiology and pathophysiology.
    Unger RH
    N Engl J Med; 1971 Aug; 285(8):443-9. PubMed ID: 4997492
    [No Abstract]   [Full Text] [Related]  

  • 15. Arginine infusion in dogs. Model for the roles of insulin and glucagon in regulating glucose turnover and free fatty acid levels.
    Cherrington AD; Kawamori R; Pek S; Vranic M
    Diabetes; 1974 Oct; 23(10):805-15. PubMed ID: 4422477
    [No Abstract]   [Full Text] [Related]  

  • 16. [Insulin and glucagon. Recent discoveries, problems and questions concerning their biosynthesis, secretion and mode of action].
    Stauffacher W
    Schweiz Med Wochenschr; 1972 Feb; 102(8):245-50. PubMed ID: 4334566
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus.
    Shah P; Vella A; Basu A; Basu R; Schwenk WF; Rizza RA
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4053-9. PubMed ID: 11095432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxytocin infusion increases plasma insulin and glucagon levels and glucose production and uptake in the normal dog.
    Altszuler N; Hampshire J
    Diabetes; 1981 Feb; 30(2):112-4. PubMed ID: 7009266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of insulin, glucagon, and free fatty acids in the regulation of ketogenesis in dogs.
    Keller U; Chiasson JL; Liljenquist JE; Cherrington AD; Jennings AS; Crofford OS
    Diabetes; 1977 Nov; 26(11):1040-51. PubMed ID: 913893
    [No Abstract]   [Full Text] [Related]  

  • 20. Catecholamine responses and their interactions with other glucoregulatory hormones.
    Vranic M; Gauthier C; Bilinski D; Wasserman D; El Tayeb K; Hetenyi G; Lickley HL
    Am J Physiol; 1984 Aug; 247(2 Pt 1):E145-56. PubMed ID: 6147092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.